Profile
RENB VRTX REGN VRNA ARGX ALNY
Company Name Lunai Bioworks Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $32.92M $121.02B $76.58B $72.68B $51.71B $46.48B
Employees 0.03K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO David H. Weinstein Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
RENB VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
RENB VRTX REGN VRNA ARGX ALNY
Last Close $1.42 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.91 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.13 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -25.65 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 992.31 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
RENB VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 513.92 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 340.99 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 74.43 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 69.96 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 200.08 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RENB VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 395.46 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.16 % - - -
Growth
RENB VRTX REGN VRNA ARGX ALNY
Asset Growth -94.95 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 100 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year -100 % 285.02 % - 2487.4 %
EBIT Growth 100 % 9.09 % -131.37 % 24.59 %
Net Income Growth -120.72 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 95.01 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 56.23 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 40.75 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -131.46 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 28.23 % - -143.33 % -107.98 %
Operating 3 Year CFG 98.41 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 97.89 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 96.91 % -100 % 40.15 % 97.08 %
EPS Growth 87.14 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 87.14 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -100.94 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -100.94 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -100.36 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 80.65 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 168.65 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 28.68 % - -144.48 % -201.54 %
Updated On 30 Jun 2025 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
RENB VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 16.78 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -1881.67 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -385.07 % 21.81 % 14.07 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 1088.68 % 19.59 % 9.28 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 94.27 % 111.4 % 141.65 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -72011.35 % 34.06 % 25.75 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM 434982962.15 % 202.64 % 187.41 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.01 0.4 0.34 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 1547.82 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 2.77 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM 522841.9 14.55 49.28 -0.85 5.67 2.02
Free Cash Flow Per Share TTM 524164 13.06 40.37 -0.85 5.58 1.68
Cash Per Share TTM 2.77 % 2459.7 % 18334.11 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 6102815287.75 % 31.71 % 35.36 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.25 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM 434982962.15 % 202.64 % 187.41 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM - 36.26 18.43 -995.27 131.1 209.96
Price To Operating Cash Flows Ratio TTM - 32.45 15.05 -126.33 148.01 173.94
Price Cash Flow Ratio TTM - 32.45 15.05 -126.33 148.01 173.94
Income Statement (TTM)
RENB VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.19B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.18B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.08 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
RENB VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.03B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $-0.02B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $16.08B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
RENB VRTX REGN VRNA ARGX ALNY
Net Income $-0.18B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to RENB
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00014 265.02
VTI Vanguard Total Stock Market Index Fund 0.00002 340.96
IWN iShares Russell 2000 Value ETF 0.00011 200.31
IWO iShares Russell 2000 Growth ETF 0.00017 339.48
VXF Vanguard Extended Market Index Fund 0.00013 217.96
HDG ProShares Hedge Replication ETF 0.000207865 52.68
UWM ProShares Ultra Russell2000 0.00120925 53.95
VTHR Vanguard Russell 3000 Index Fund 0.00008 305.54
IWC iShares Micro-Cap ETF 0.00093 168.85
URTY ProShares UltraPro Russell2000 0.000967487 64.84
VTWV Vanguard Russell 2000 Value Index Fund 0.00113 176.901
VTWG Vanguard Russell 2000 Growth Index Fund 0.00182 248.074
VTWO Vanguard Russell 2000 Index Fund 0.0014 107.1
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 50.14
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00003 114.86
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00003 114.84
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00002 52.46
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00002 52.45
VBINX Vanguard Balanced Index Fund Investor Shares 0.00002 52.45
GERM ETFMG Treatments, Testing and Advancements ETF 0.22 19.1577
VTSAX Vanguard Total Stock Market Index Fund 0.00002 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00013 165.43
VITSX Vanguard Total Stock Market Index Fund 0.00002 166.06
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00013 165.44
AVSC Avantis U.S. Small Cap Equity ETF 0 65.27
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 479.23
DCOR Dimensional ETF Trust 0.0000109 76.48
VEMPX Vanguard Extended Market Index InstlPlus 0.00013 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 311.51
RSSL Global X Funds 0 103.93
Unlock